KTEP - El Paso, Texas

Alison Kodjak

Jenna Neikirk was nearing the end of her first pregnancy when her blood pressure shot up to dangerous levels.

"I started feeling splotchy and hot, just kind of uncomfortable, so I took my blood pressure at work and it was 160 over 120," she says. Neikirk's a physical therapist in Atlanta and knew that level was alarmingly high.

She left work and walked over to her obstetrician's office, which was in the same medical complex.

The couch is dark brown corduroy with lumpy cushions. There are a few telltale smears of food, maybe yogurt or a banana, and some crumbs here and there. It's a well-loved piece of furniture.

Margaret Siebers plops herself down in the center and reaches out to baby daughter Frances, who climbs onto her mother's lap to breastfeed.

"This is where I spent several months," says Siebers, with a shrug. Her 4-year-old, Violet, runs around nearby. "I could come downstairs and sit on the couch."

Voters in three traditionally Republican states supported ballot measures to extend Medicaid benefits to more low-income adults.

The results highlight the divide between voters, even in conservative states, who generally support providing health benefits to the poor, and conservative politicians who have rejected the expansion, which is a central part of the Affordable Care Act.

Copyright 2018 NPR. To see more, visit http://www.npr.org/.

DAVID GREENE, HOST:

There is a growing unease among Americans. Many see a lack of civility in our politics, and some fear that this could lead to more acts of violence.

RACHEL MARTIN, HOST:

It's time for consumers who buy their own health insurance to start shopping for policies for next year. Open enrollment for Affordable Care Act coverage starts Thursday across most of the country.

But the shopping and buying experience will vary widely, depending on where people live.

In California, for example, where political leaders have always been supportive of the Affordable Care Act, legislators have allocated $100 million for outreach.

It wasn't all that long ago that Grant Burningham was homeless and sleeping in a tent in the woods.

"That's hard for me to talk about because I thought I had reached the end," he says.

Burningham, a former financial adviser from Bountiful, Utah, developed serious medical problems 17 years ago. Back in 2001, Burningham offered to donate his stem cells to his sister for a transplant. It required multiple procedures, and each time Burningham was given high doses of a medication to boost his immune system.

"And then I got really sick," he says.

The Trump administration says it plans to change how Medicare pays for some expensive drugs for cancer and arthritis in a move to bring the costs more in line with the prices paid in European countries.

"For decades, other countries have rigged the system so that American patients are charged much more," President Trump said Thursday in a speech at the U.S. Department of Health and Human Services, which administers Medicare. "American patients pay more, so other countries can pay less."

Rural Americans are preoccupied with the problems of opioid and drug addiction in their communities, citing it as a worry on par with concerns about local jobs and the economy, according to a new poll from NPR, the Robert Wood Johnson Foundation and the Harvard T.H. Chan School of Public Health.

If you're looking for cheaper health insurance, a whole host of new options will hit the market starting Tuesday.

But buyer beware!

If you get sick, the new plans – known as short-term, limited duration insurance — may not pay for the medical care you need.

Copyright 2018 NPR. To see more, visit http://www.npr.org/.

RACHEL MARTIN, HOST:

Sometimes IV bags are hard for hospitals to come by. Other times it's injectable folic acid to treat anemias. Right now, the tissue-numbing agent lidocaine is in short supply.

Shortages of commonplace generic drugs have plagued hospitals in recent years. And with short supplies and fewer suppliers for key drugs, there have been price increases.

Consumers who buy insurance through the Affordable Care Act markets may be pleasantly surprised this fall as average premiums are forecast to rise much less than in recent years.

The price of a 2019 policy sold on the ACA exchanges will increase less than 4 percent, according to an analysis of preliminary filings from insurers in all 50 states by ACASignups.net, a website and blog run by analyst Charles Gaba that tracks ACA enrollment and insurer participation.

And those insurers are expanding their offerings.

A Texas man has a heart attack – and good medical insurance – and still finds himself on the hook for $109,000 in medical bills.

Another man in Florida owed $3,400 for a CT scan, after his insurance company pays its part.

Several states are questioning the cost of using pharmacy middlemen to manage their prescription drug programs in a movement that could shake up the complex system that manages how pharmaceuticals are priced and paid for.

Copyright 2018 NPR. To see more, visit http://www.npr.org/.

AILSA CHANG, HOST:

People who don't get insurance through their jobs will now be able to buy short-term policies that may be cheaper than Affordable Care Act coverage. These plans won't have to cover as many medical services and are exempt from covering people with pre-existing conditions.

The departments of Health and Human Services, Labor and Treasury announced new rules Wednesday that make it easier for consumers to replace ACA insurance with these short-term policies.

Copyright 2018 NPR. To see more, visit http://www.npr.org/.

NOEL KING, HOST:

Copyright 2018 NPR. To see more, visit http://www.npr.org/.

DAVID GREENE, HOST:

Copyright 2018 NPR. To see more, visit http://www.npr.org/.

AILSA CHANG, HOST:

Rising drug prices, especially in Medicaid, are straining state budgets. Lawmakers across the country are being forced to make tough choices between giving the poor access to medications and other budget priorities, like education.

Eight months pregnant, the drug sales representative wore a wire for the FBI around her bulging belly as she recorded conversations with colleagues at a conference in Chicago. Her code name? Pampers.

Copyright 2019 NPR. To see more, visit https://www.npr.org.

RENEE MONTAGNE, HOST:

Over the last six years, enough opioids were shipped to the state of Missouri to give every resident 260 pills.

The finding comes from a report released Thursday by Sen. Claire McCaskill, D-Mo. It's the latest in a series of investigations by the senator into the role of drugmakers, distributors and other industry players in fueling the opioid epidemic.

Copyright 2018 NPR. To see more, visit http://www.npr.org/.

RACHEL MARTIN, HOST:

Copyright 2018 NPR. To see more, visit http://www.npr.org/.

ARI SHAPIRO, HOST:

A federal judge has blocked work requirements for Medicaid patients in Kentucky, just days before new rules mandated by Gov. Matt Bevin's administration were set to go into effect.

In Friday's ruling, U.S. District Judge James Boasberg called the Trump administration's approval of the program, Kentucky HEALTH, "arbitrary and capricious."

Rachel Osborn knows kids who slept in the immigrant detention centers in Texas that have dominated recent headlines.

"We have kids who will say that was the worst part of their journey," Osborn says. "They were traveling for weeks and the hardest part was being in this freezing cold room where, you know, they were fed a cold sandwich and had a thin blanket to shiver under."

And they had no parent or caregiver to comfort them and make them feel safe.

The Trump administration's decision to abandon the Affordable Care Act in an ongoing court challenge could affect some of the most popular pillars of the law — further intensifying the fight over health care in the middle of an election year.

Legislation that would allow terminally ill patients to get access to experimental drugs is headed to the president's desk.

The House on Tuesday passed a "right-to-try" bill that was approved by the Senate in 2017.

"People who are terminally ill should not have to go from country to country to find a cure," said Rep. Michael Burgess, R-Texas, on the House floor Tuesday.

The bill, which President Trump is expected to sign, has patient advocates divided.

Copyright 2019 NPR. To see more, visit https://www.npr.org.

MARY LOUISE KELLY, HOST:

Updated 11:16 EDT: This story now includes information about the Food and Drug Administration's release of a list of complaints against brand-name drugmakers for hindering access to samples for generic testing.

When Celgene Corp. first started marketing the drug Revlimid to treat multiple myeloma in 2006, the price was $6,195 for 21 capsules, a month's supply.

Pages